Answer
Promixin (colistimethate sodium) should be given during pregnancy only if benefits outweigh potential risks: human pregnancy safety is unestablished, animal studies indicate no teratogenic potential, but placental transfer creates potential for foetal toxicity.
Sources for this answer
- Promixin 1 million International Units (IU) Powder for Nebuliser SolutionZambon UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 15Document updated
Sources checked